Correlation between peripheral hemodynamic changes and left ventricular diastolic function in hypertensive patients...

Area of Science:

• Cardiology
• Pharmacology
• Hypertension Research

Background:

• Essential hypertension is linked to altered hemodynamic parameters and impaired left ventricular diastolic function.
• Alpha-1-adrenolytic agents are used to manage hypertension, but their effects on vascular and cardiac remodeling require further investigation.

Purpose of the Study:

• To evaluate the effects of chronic urapidil treatment on peripheral arterial hemodynamics and left ventricular diastolic function in patients with essential hypertension.

Main Methods:

• A 6-month study involving 15 patients with mild to moderate essential hypertension treated with urapidil (60 mg b.i.d.).
• Peripheral hemodynamic and cardiac parameters were assessed using duplex scanner and plethysmography at baseline, 6 weeks, and 6 months.
• Key parameters included blood pressure, heart rate, arterial compliance, characteristic impedance, forearm resistances, and left ventricular diastolic dimensions and volumes.

Main Results:

• Urapidil significantly reduced mean blood pressure and forearm resistances, while increasing arterial compliance and characteristic impedance.
• Significant improvements were observed in left ventricular diastolic parameters, including reduced posterior wall and interventricular septum thickness, increased end-diastolic volume, and decreased mass/volume index.
• Arterial compliance changes correlated significantly with improvements in left ventricular diastolic function and dimensions.

Conclusions:

• Chronic urapidil treatment effectively lowers blood pressure and improves peripheral arterial hemodynamics in hypertensive patients.
• Urapidil treatment also leads to significant regression of functional modifications in left ventricular diastolic function.
• The findings suggest that urapidil's antihypertensive efficacy, combined with improved arterial compliance and reduced sympathetic activation, contributes to the observed diastolic function improvements.